MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
Dr Roger Williams, group leader in LMB’s PNAC Division, has been elected as a Fellow of the Academy of Medical Sciences. The Academy promotes the translation of advances in medical science into benefits for patients and the population at large: fellowship of the Academy is based on exceptional contributions to the medical sciences.
Roger’s research focuses on determining the structure of protein complexes involved in phospholipid signaling and sorting pathways within cells.
Dr Sarah Teichmann has won the Biochemical Society’s 2011 Colworth Medal. The medal is awarded annually to a biochemist under the age of 35 for outstanding research achievement. The award was made in recognition of her groundbreaking work on elucidating principles of the evolution and dynamics of transcriptional regulatory networks and protein complexes.
LMB scientist Dr Sarah Teichmann has received a ‘2009 Women of the Future’ award as ‘Science and Technology Woman of the Future’ for her major contribution to scientists’ interpretation of the human genome and an understanding of how evolution shapes the molecules and processes of life.
Human (and other) genome projects are probably one of the most significant advances in biological and medicinal science in the past 20 years. Sarah’s research represents the important next stage.
The MRC Units on the Addenbrooke’s campus, including LMB, have recently been awarded the “Workplace Travel Plan Award Certificate of Commitment” in recognition of their efforts to develop a travel plan to reduce the amount of travel generated by MRC’s activities.
Speaking on behalf of LMB’s Green Committee, Dr Christine Barrie said “We are delighted that all our efforts to address sustainable travel have been recognised.
Competition Winners Lizzy Day, Fan Cheng,
Sarah Leigh-Brown, Harry Harris, Daniel Naujoks.
Image courtesy BBSRCA team of early career scientists from Cambridge University and Imperial College London – led by Lizzy Day, a second year PhD student at LMB – won the 2009 Biotechnology YES (Young Entrepreneurs Scheme) title.
Based in Cambridge, UK, Bicycle Therapeutics, the latest LMB spin out, will combine the most desirable features of small molecules and biologics to create highly specific and stable drugs.
Bicycle Therapeutics has developed a new novel technology platform using phage display to select peptidic sequences that are cyclized on a chemical core.